AVALIAÇÃO DO POTENCIAL TRIPANOCIDA DE DERIVADOS TIOSSEMICARBAZONAS: UMA REVISÃO
DOI:
https://doi.org/10.47820/recima21.v2i9.658Palavras-chave:
Drug synthesis; Trypanocidal activity; Trypanosoma cruzi; Thiosemicarbazones.Resumo
Neglected diseases are a group of communicable diseases that mainly affect tropical regions in developing countries. Among this group of diseases is Chagas disease, which has been classified among the six most important parasitic diseases in the world, and it is estimated that more than one billion people are at risk in countries that are considered endemic. The aim of this study is to conduct a literature review on the trypanocidal activity of thiosemicarbazone derivatives. The study is a review research that used 31 articles to highlight the scientific findings on the trypanocidal activity of the derivatives in question. Articles were included in the time estimate between 2010 - 2021 (last 12 years). The search and selection of the reference studies was performed in Scielo, Science Direct, PubMed and Google Academic databases. The literature highlights that thiosemicarbazones are considered privileged compounds with a wide scientific interest due to their diverse chemical and biological properties, such as: antitumor, antibacterial, antiviral, antiprotozoal, and anti-chagasic. The studies presented here, which demonstrate the investigations of compounds of this class and their derivatives, are an important step towards the conception of therapeutic methods against Trypanosoma cruzi. New studies are necessary to elucidate in an even more specific way the effects of these derivatives in vivo, in order to obtain an alternative pharmacological therapy for Chagas disease.
Downloads
Referências
ARAÚJO, D. L.; SOUZA, M. S.; DA SILVA MACHADO, B. A.; MASCARENHAS, J. M. F.; ALVES, S. P.; DO NASCIMENTO, M. L. M.; DE OLIVEIRA, J. E. G. Clinical and symptomatological characterization regarding Chagas disease caused by the Trypanosoma cruzi parasite. Research, Society and Development, v. 10, n. 5, p. e16110514873-e16110514873, 2021.
ARRÚA, E. C.; SEREMETA, K. P.; BEDOGNI, G. R.; OKULIK, N. B.; SALOMON, C. J. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of Chagas disease: a review. Acta tropica, v. 198, 2019.
BOLETIM EPIDEMIOLÓGICO. Brasília: Secretaria de Vigilância em Saúde, 2015. v. 46, n. 21.
BELTRAN-HORTELANO, I.; ALCOLEA, V.; FONT, M.; PÉREZ-SILANES, S. The role of imidazole and benzimidazole heterocycles in Chagas disease: A review. European Journal of Medicinal Chemistry, 2020.
BRASIL. Situação epidemiológica. Brasília: Ministério da Saúde. [20--].
COSTA, L. B. Avaliação farmacológica de novas hidrazonas, candidatas a fármacos leishmanicida e tripanocida. 2015. Thesis (Doctoral) – Universidade Federal de Pernambuco, Recife, 2015.
DA SILVA, A. P.; DANTAS, G. M. S.; DA SILVA, P. I. F.; DE MEDEIROS, A. N. G.; JUNIOR, T. N. Doenças negligenciadas e indústria farmacêutica: o caso da Doença de Chagas. Research, Society and Development, v. 10, n. 2, p. e21110212419-e21110212419, 2021.
DA SILVA, A. A.; DA SILVA, P. I. M.; LOPES, C. D.; DE ALBUQUERQUE, S.; VALLE, M. S. Synthesis, characterization and antichagasic evaluation of thiosemicarbazones prepared from chalcones and dibenzalacetones. Journal of Molecular Structure, v. 1232, 2021.
DELGADO-MALDONADO, T.; NOGUEDA-TORRES, B.; ESPINOZA-HICKS, J. C.; VÁZQUEZ-JIMÉNEZ, L. K.; PAZ-GONZÁLEZ, A. D.; JUÁREZ-SALDÍVAR, A.; RIVERA, G. Synthesis and biological evaluation in vitro and in silico of N-propionyl-N′-benzeneacylhydrazone derivatives as cruzain inhibitors of Trypanosoma cruzi. Molecular Diversity, p. 1-12, 2020.
DE SOUZA, M. L.; JUNIOR, C. D. O. R.; FERREIRA, R. S.; ESPINOZA CHÁVEZ, R. M.; FERREIRA, S. B. W.; ANDRICOPULO, A. D. Carbamoyl Imidazoles As Potent, Reversible and Competitive Cruzain Inhibitors with in vitro and in vivo Trypanocidal. Activity: A Structure-Based Drug Design Approach, 2019.
ECHEVERRIA, L. E.; MORILLO, C. A. American trypanosomiasis (Chagas disease). Infectious Disease Clinics, v. 33, n. 1, p. 119-134, 2019.
HASSAN, M.; GHAFFARI, R.; SARDARI, S.; FARAHANI, Y. F.; MOHEBBI, S. Discovery of novel isatin-based thiosemicarbazones: synthesis, antibacterial, antifungal, and antimycobacterial screening. Research in Pharmaceutical Sciences, v. 15, n. 3, p. 281, 2020.
HEFFETER, P.; PAPE, V. F.; ENYEDY, É. A.; KEPPLER, B. K.; SZAKACS, G.; KOWOL, C. R. Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development. Antioxidants & redox signaling, v. 30, n. 8, p. 1062- 1082, 2019.
Downloads
Publicado
Como Citar
Edição
Secção
Categorias
Licença
Direitos de Autor (c) 2021 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.